RT Journal Article
SR Electronic
T1 Inexpensive multi-patient respiratory monitoring system for helmet ventilation during COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.29.20141283
DO 10.1101/2020.06.29.20141283
A1 ,
A1 Bourrianne, Philippe
A1 Chidzik, Stanley
A1 Cohen, Daniel
A1 Elmer, Peter
A1 Hallowell, Thomas
A1 Kilbaugh, Todd J.
A1 Lange, David
A1 Leifer, Andrew M.
A1 Marlow, Daniel R.
A1 Meyers, Peter D.
A1 Normand, Edna
A1 Nunes, Janine
A1 Oh, Myungchul
A1 Page, Lyman
A1 Periera, Talmo
A1 Pivarski, Jim
A1 Schreiner, Henry
A1 Stone, Howard A.
A1 Tank, David W.
A1 Thiberge, Stephan
A1 Tully, Christopher
YR 2020
UL http://medrxiv.org/content/early/2020/11/09/2020.06.29.20141283.abstract
AB Helmet non-invasive ventilation (NIV) is a form of continuous positive applied pressure that has been used to provide respiratory support to COVID-19 patients. Helmet NIV is low-cost, readily available, provides viral filters between the patient and clinician, and may reduce the need for invasive ventilation. Its widespread adoption has been limited, however, by the lack of a respiratory monitoring system needed to address known safety vulnerabilities and to monitor patients. To address these safety and clinical needs, we developed an inexpensive respiratory monitoring system based on readily available components that is suitable for local manufacture. Open-source design and manufacturing documents are provided. The system is compatible with the Sea-Long Medical Systems COVID-19 Helmet [1] and the Subsalve Oxygen Treatment Hood [2]. The monitoring system comprises one or more flow, pressure and CO2 sensors on the expiratory path of the helmet circuit and a central remote station to monitor up to 20 patients. The system reports flow, pressure, CO2 concentration, respiratory rate, tidal volume equivalent, peak inspiratory pressure (PIP), positive end-expiratory pressure (PEEP) and the ratio of inspiratory time to expiratory time (I:E) and will sound an alarm based on clinician-set thresholds. The system is validated in bench tests, in human-subject tests on healthy volunteers, and in experiments that compare respiratory features obtained at the expiratory path to simultaneous ground-truth measurements from proximal sensors. Measurements of flow and pressure at the expiratory path are shown to closely track proximal sensor readings. However, at high flow rates, the tidal volumes reported via the expiratory path are underestimated by up to -20% compared to the proximal sensor measurements. This effect is attributed to the expansion and contraction of the helmet volume and is associated with slow response to sharp features in the respiratory waveforms. The average CO2 concentrations measured through the expiratory path agree with previous reports [3], while the observed fluctuations suggest incomplete mixing of exhaled CO2 with the helmet flow. Flow and pressure monitoring correlates with the average CO2 concentration in the helmet and responds sufficiently fast to detect deviations from safe CO2 levels.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by National Science Foundation grants OAC-1836650, PHY-2031509 and IOS-1845137.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Human subject tests were conducted in accordance with IRB protocol #12857 approved by Princeton University's Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRelevant human subject data is included as supplementary material. All design files are included as supplementary material. Links to software repositories are included in the manuscript.